Skip to content

Zai Lab

US · ZLAB #2554 by market cap Listed 2017
21.03 -0.89 -4.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 20.89 -4.70%
After-hours 21.03 0.00%
Overnight 21.06 -3.92%
27.0016.4821.032026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on ZLAB?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -7.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 7.2% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall C+

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability D+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 58.5% Better than 73%
Operating margin -48.6% Better than 9%
Net margin -38.1% Better than 10%
Return on equity -22.6% Better than 15%
Return on invested capital -21.0% Better than 13%
Momentum B-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -19.1% Better than 32%
6-month return 13.0% Better than 76%
12-month return (ex latest month) 10.1% Better than 46%
Distance below 52-week high 27.5% Better than 46%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.4x Better than 66%
Debt to assets 19.1% Better than 57%
Interest coverage -33.3x Better than 8%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 87.0% Better than 80%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -14.51%
1M -16.15%
3M -19.18%
6M +11.80%
YTD +19.22%
1Y +4.06%
3Y -25.61%
5Y -75.01%

Key statistics

Price & volume

Prev close
21.92
Open
20.99
Day range
20.02 - 21.15
Avg price
20.94
Volume
1.44M
Turnover
30.20M
Amplitude
5.16%
52-week range
15.96 - 29.02

Valuation

P/E
-13.14
P/E (TTM)
-11.68
P/B
4.20
EPS
-1.60
Net profit
-179.91M
Net assets
563.24M

Share structure

Market cap
2.36B
Float cap
1.96B
Shares out
112.44M
Float shares
93.42M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2017-09-20
52-week range 39% of range
15.96 29.02

27.5% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-20.95M net over the window

Short interest

Shares short
8.09M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Zai Lab (ZLAB)?

Zai Lab last traded at 21.03. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Zai Lab's market cap?

About 2.36B.

What is the P/E ratio of Zai Lab?

The trailing twelve-month P/E is -11.68. The Valuation tab shows it against the stock's own five-year range.

Does Zai Lab pay a dividend?

Zai Lab does not currently pay a regular dividend.

Is Zai Lab a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 39.33, which implies 87.0% upside from the current price. This is not investment advice.

What is Zai Lab's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Zai Lab a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Zai Lab discussion 0 comments

Add a comment